Suggested functions for prolyl oligopeptidase: A puzzling paradox

Clinica Chimica Acta

Volumn 377, Issue 1-2, 2007, Pages 50-61

  Brandt, Inger ^a   Scharpé, Simon ^a   Lambeir, Anne Marie ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Brain; Inositolphosphate; Neuropeptide; Prolyl oligopeptidase; Serine protease

Indexed keywords

[[2 PHENYLCYCLOPROPYL] CARBONYL] 2 [(THIAZOLIDIN 3 YL)CARBONYL] OCTAHYDRO 1H INDOLE; ALPHA INTERFERON; ALPHA INTERMEDIN; AMINO ACID; AMYLOID BETA PROTEIN; ARGIPRESSIN; CARBAMAZEPINE; CYSTEINE PROTEINASE; DESIPRAMINE; DOXORUBICIN; FLUOXETINE; GONADORELIN; LITHIUM; N BENZYL 2 [[2 (HYDROXYACETYL) 1 PYRROLIDINYL]CARBONYL] 1 PYRROLIDINECARBOXAMIDE; N BENZYLOXYCARBONYL THIOPROLYL THIOPROLINALDIMETHYLACETAL; NEUROPEPTIDE; NEUROTENSIN; OCTADECANEUROPEPTIDE; OLANZAPINE; PHOSPHATIDYLINOSITIDE; PROLYL ENDOPEPTIDASE; PROLYL ENDOPEPTIDASE INHIBITOR; PROTIRELIN; S 17092; SUBSTANCE P; VALPROIC ACID;

ALZHEIMER DISEASE; AMNESIA; BACTERIUM; BEHAVIOR; BIPOLAR DISORDER; CANCER; CARDIOMYOPATHY; CELIAC DISEASE; CELL DEATH; CELL DIFFERENTIATION; CELL INVASION; CELL MATURATION; CELL PROLIFERATION; CHAGAS DISEASE; DEGENERATIVE DISEASE; DEPRESSION; EATING DISORDER; ENZYME ACTIVITY; HORMONE METABOLISM; HOST CELL; HUMAN; HYPERTENSION; INFLAMMATION; LEARNING; MAMMAL; MELANOMA; MEMORY; MOOD DISORDER; NERVE CELL DIFFERENTIATION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SAMPLE; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TRANSIENT ISCHEMIC ATTACK; TRYPANOSOMA CRUZI;

ANIMALS; CELIAC DISEASE; DISEASE; HUMANS; MEMORY; NEUROPEPTIDES; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 33845477051     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.09.001     Document Type: Review

References (113)

1. Venäläinen J., Juvonen R.O., and Männistö P.T. Evolutionary relationships of the prolyl oligopeptidase family enzymes. Eur J Biochem 271 (2004) 2705-2715
2. Goossens F., De Meester I., Vanhoof G., and Scharpé S. Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids. Eur J Clin Chem Clin Biochem 34 (1996) 17-22
3. Kamei H., Ueki T., Obi Y., Fukagawa Y., and Oki T. Protective effect of eurystatins A and B, new prolyl endopeptidase inhibitors, on scopolamine-induced amnesia in rats. Jpn J Pharmacol 60 (1992) 377-380
4. Portevin B., Benoist A., Remond G., et al. New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives. J Med Chem 39 (1996) 2379-2391
5. Tsuru D., Yoshimoto T., Koriyama N., and Furukawa S. Thiazolidine derivatives as potent inhibitors specific for prolyl endopeptidase. J Biochem (Tokyo) 104 (1988) 580-586
6. Yoshimoto T., Kado K., Matsubara F., Koriyama N., Kaneto H., and Tsura D. Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect. J Pharmacobio-dyn 10 (1987) 730-735
7. Kato T., Nakano T., Kojima K., Nagatsu T., and Sakakibara S. Changes in prolyl endopeptidase during maturation of rat brain and hydrolysis of substance P by the purified enzyme. J Neurochem 35 (1980) 527-535
8. Moriyama A., Nakanishi M., and Sasaki M. Porcine muscle prolyl endopeptidase and its endogenous substrates. J Biochem (Tokyo) 104 (1988) 112-117
9. Orlowski M., Wilk E., Pearce S., and Wilk S. Purification and properties of a prolyl endopeptidase from rabbit brain. J Neurochem 33 (1979) 461-469
10. Yoshimoto T., Simmons W.H., Kita T., and Tsuru D. Post-proline cleaving enzyme from lamb brain. J Biochem (Tokyo) 90 (1981) 325-334
11. Aoyagi T., Wada T., Nagai M., et al. Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer's disease. Experientia 46 (1990) 94-97
12. Hagihara M., and Nagatsu T. Post-proline cleaving enzyme in human cerebrospinal fluid from control patients and parkinsonian patients. Biochem Med Metab Biol 38 (1987) 387-391
13. Mantle D., Falkous G., Ishiura S., Blanchard P.J., and Perry E.K. Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. Clin Chim Acta 249 (1996) 129-139
14. Bär J.W., Rahfeld J.U., Schulz I., et al. Prolyl endopeptidase cleaves the apoptosis rescue peptide humanin and exhibits an unknown post-cysteine cleavage specificity. Adv Exp Med Biol 575 (2006) 103-108
15. Fiedorowicz A., Figiel I., Kaminska B., Zaremba M., Wilk S., and Oderfeld-Nowak B. Dentate granule neuron apoptosis and glia activation in murine hippocampus induced by trimethyltin exposure. Brain Res 912 (2001) 116-127
16. Odaka C., Mizuochi T., Shirasawa T., Morain P., and Checler F. Murine T cells expressing high activity of prolyl endopeptidase are susceptible to activation-induced cell death. FEBS Lett 512 (2002) 163-167
17. Valdivia A., Irazusta J., Fernandez D., Mugica J., Ochoa C., and Casis L. Pyroglutamyl peptidase I and prolyl endopeptidase in human semen: increased activity in necrozoospermia. Regul Pept 122 (2004) 79-84
18. Rossner S., Schulz I., Zeitschel U., Schliebs R., Bigl V., and Demuth H.U. Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer's disease. Neurochem Res 30 (2005) 695-702
19. Schulz I., Zeitschel U., Rudolph T., et al. Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion. J Neurochem 94 (2005) 970-979
20. Williams R.S., Eames M., Ryves W.J., Viggars J., and Harwood A.J. Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate. EMBO J 18 (1999) 2734-2745
21. Williams R.S., Cheng L., Mudge A.W., and Harwood A.J. A common mechanism of action for three mood-stabilizing drugs. Nature 417 (2002) 292-295
22. Schulz I., Gerhartz B., Neubauer A., et al. Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. Eur J Biochem 269 (2002) 5813-5820
23. Toide K., Shinoda M., Fujiwara T., and Iwamoto Y. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats. Pharmacol Biochem Behav 56 (1997) 427-434
24. Shinoda M., Matsuo A., and Toide K. Pharmacological studies of a novel prolyl endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery occlusion. Eur J Pharmacol 305 (1996) 31-38
25. Shinoda M., Miyazaki A., and Toide K. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and on cholinergic and peptidergic neurons in rats with ibotenate-induced lesions of the nucleus basalis magnocellularis. Behav Brain Res 99 (1999) 17-25
26. Miyazaki A., Toide K., Sasaki Y., Ichitani Y., and Iwasaki T. Effect of a prolyl endopeptidase inhibitor, JTP-4819, on radial maze performance in hippocampal-lesioned rats. Pharmacol Biochem Behav 59 (1998) 361-368
27. Toide K., Okamiya K., Iwamoto Y., and Kato T. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on prolyl endopeptidase activity and substance P- and arginine-vasopressin-like immunoreactivity in the brains of aged rats. J Neurochem 65 (1995) 234-240
28. Morain P., Lestage P., De Nanteuil G., et al. S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies. CNS Drug Rev 8 (2002) 31-52
29. Schneider J.S., Giardiniere M., and Morain P. Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys. Neuropsychopharmacology 26 (2002) 176-182
30. Shishido Y., Furushiro M., Tanabe S., et al. ZTTA, a postproline cleaving enzyme inhibitor, improves cerebral ischemia-induced deficits in a three-panel runway task in rats. Pharmacol Biochem Behav 55 (1996) 333-338
31. Shishido Y., Furushiro M., Tanabe S., Shibata S., Hashimoto S., and Yokokura T. Effects of prolyl endopeptidase inhibitors and neuropeptides on delayed neuronal death in rats. Eur J Pharmacol 372 (1999) 135-142
32. Saito M., Hashimoto M., Kawaguchi N., Fukami H., Tanaka T., and Higuchi N. Synthesis and inhibitory activity of acyl-peptidyl-prolinalderivatives toward post-proline cleaving enzyme as nootropic agents. J Enzyme Inhib 3 (1990) 163-178
33. Morain P., Robin J.L., De Nanteuil G., Jochemsen R., Heidet V., and Guez D. Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study. Br J Clin Pharmacol 50 (2000) 350-359
34. Umemura K., Kondo K., Ikeda Y., Kobayashi T., Urata Y., and Nakashima M. Pharmacokinetics and safety of JTP-4819, a novel specific orally active prolyl endopeptidase inhibitor, in healthy male volunteers. Br J Clin Pharmacol 43 (1997) 613-618
35. Jiang C.H., Tsien J.Z., Schultz P.G., and Hu Y.H. The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc Natl Acad Sci U S A 98 (2001) 1930-1934
36. Gibson A.M., Edwardson J.A., and McDermott J.R. Post mortem levels of some brain peptidases in Alzheimer's disease: reduction in proline endopeptidase activity in cerebral cortex. Neurosci Res Commun 9 (1991) 73-81
37. Ichai C., Chevallier N., Delaere P., et al. Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease. J Neurochem 62 (1994) 645-655
38. Terwel D., Bothmer J., Wolf E., Meng F.P., and Jolles J. Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia. J Neurol Sci 161 (1998) 47-56
39. Laitinen K.S., van Groen T., Tanila H., Venäläinen J.I., Männistö P.T., and Alafuzoff I. Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation. Neuroreport 12 (2001) 3309-3312
40. Maes M., Goossens F., Scharpé S., Meltzer H.Y., D'Hondt P., and Cosyns P. Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biol Psychiatry 35 (1994) 545-552
41. Maes M., Goossens F., Scharpé S., Calabrese J., Desnyder R., and Meltzer H.Y. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res 58 (1995) 217-225
42. Van Gool A.R., Van Ojik H.H., Kruit W.H.J., et al. Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients. J Interferon Cytokine Res 24 (2004) 411-415
43. Breen G., Harwood A.J., Gregory K., et al. Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients. Bipolar Disord 6 (2004) 156-161
44. Momeni N., Nordstrom B.M., Horstmann V., Avarseji H., and Sivberg B.V. Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders. BMC Psychiatry 5 (2005) 27
45. Maes M., Monteleone P., Bencivenga R., et al. Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa. Psychoneuroendocrinology 26 (2001) 17-26
46. Sedo A., Krepela E., and Kasafirek E. Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma. J Cancer Res Clin Oncol 117 (1991) 249-253
47. Zima T., Tesar V., Mantle D., et al. Acute doxorubicin (adriamycin) dosage does not reduce cardiac protein synthesis in vivo, but decreases diaminopeptidase I and proline endopeptidase activities. Exp Mol Pathol 70 (2001) 154-161
48. Kamori M., Hagihara M., Nagatsu T., Iwata H., and Miura T. Activities of dipeptidyl peptidase II, dipeptidyl peptidase IV, prolyl endopeptidase, and collagenase-like peptidase in synovial membrane from patients with rheumatoid arthritis and osteoarthritis. Biochem Med Metab Biol 45 (1991) 154-160
49. Hashimoto Y., Kakegawa H., Narita Y., et al. Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis. Biochem Biophys Res Commun 283 (2001) 334-339
50. Kakegawa H., Matano Y., Inubushi T., and Katunuma N. Significant accumulations of cathepsin B and prolylendopeptidase in inflammatory focus of delayed-type hypersensitivity induced by Mycobacterium tuberculosis in mice. Biochem Biophys Res Commun 316 (2004) 78-84
51. Cicilini M.A., Ramos P.S., Vasquez E.C., and Cabral A.M. Heart prolyl endopeptidase activity in one-kidney, one clip hypertensive rats. Braz J Med Biol Res 27 (1994) 2821-2830
52. Dauch P., Masuo Y., Vincent J.P., and Checler F. A survey of the cerebral regionalization and ontogeny of eight exo- and endopeptidases in murines. Peptides 14 (1993) 593-599
53. Szappanos A.E., Lakics V., and Erdo S.L. Pronounced increase in prolyl endopeptidase activity in primary cultures of rat cerebral cortex during neuronal differentiation. Neurobiology (Bp) 2 (1994) 211-221
54. Browne P., and O'Cuinn G. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro. Eur J Biochem 137 (1983) 75-87
55. Walter R. Partial purification and characterization of post-proline cleaving enzyme: enzymatic inactivation of neurohypophyseal hormones by kidney preparations of various species. Biochim Biophys Acta 422 (1976) 138-158
56. Faivre-Bauman A., Loudes C., Barret A., Tixier-Vidal A., and Bauer K. Possible role of neuropeptide degrading enzymes on thyroliberin secretion in fetal hypothalamic cultures grown in serum free medium. Neuropeptides 7 (1986) 125-138
57. Friedman T.C., and Wilk S. Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase. J Neurochem 46 (1986) 1231-1239
58. Mendez M., Cruz C., Joseph-Bravo P., Wilk S., and Charli J.L. Evaluation of the role of prolyl endopeptidase and pyroglutamyl peptidase I in the metabolism of LHRH and TRH in brain. Neuropeptides 17 (1990) 55-62
59. Salers P., Ouafik L.H., Giraud P., Dutour A., Maltese J.Y., and Oliver C. Evidence for pyroglutamyl peptidase I and prolyl endopeptidase activities in the rat insulinoma cell line RINm 5F: lack of relationship with TRH metabolism. Mol Cell Biochem 106 (1991) 15-24
60. 14C]leucine in rat amygdaloid and cortical slices. Pharm Res 16 (1999) 463-465
61. Shinoda M., Okamiya K., and Toide K. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on thyrotropin-releasing hormone-like immunoreactivity in the cerebral cortex and hippocampus of aged rats. Jpn J Pharmacol 69 (1995) 273-276
62. Toide K., Iwamoto Y., Fujiwara T., and Abe H. JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer. J Pharmacol Exp Ther 274 (1995) 1370-1378
63. Bellemère G., Vaudry H., Morain P., and Jegou S. Effect of prolyl endopeptidase inhibition on arginine-vasopressin and thyrotrophin-releasing hormone catabolism in the rat brain. J Neuroendocrinol 17 (2005) 306-313
64. Miura N., Shibata S., and Watanabe S. Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats. Neurosci Lett 196 (1995) 128-130
65. Miura N., Shibata S., and Watanabe S. Z-321, a prolyl endopeptidase inhibitor, augments the potentiation of synaptic transmission in rat hippocampal slices. Behav Brain Res 83 (1997) 213-216
66. Bellemère G., Morain P., Vaudry H., and Jegou S. Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and alpha-melanocyte-stimulating hormone breakdown in the rat brain. J Neurochem 84 (2003) 919-929
67. Schönlein C., Heins J., and Barth A. Purification and characterization of prolyl endopeptidase from pig brain. Biol Chem Hoppe-Seyler 371 (1990) 1159-1164
68. Kusuhara M., Hachisuka H., Nakano S., and Sasai Y. Purification and characterization of prolyl endopeptidase from rat skin. J Dermatol Sci 6 (1993) 138-145
69. Taylor W.L., and Dixon J.E. Catabolism of neuropeptides by a brain proline endopeptidase. Biochem Biophys Res Commun 94 (1980) 9-15
70. Checler F., Amar S., Kitabgi P., and Vincent J.P. Catabolism of neurotensin by neural (neuroblastoma clone N1E115) and extraneural (HT29) cell lines. Peptides 7 (1986) 1071-1077
71. Bai J.P.F. Stability of neurotensin and acetylneurotensin 8-13 in brush-border membrane, cytosol and homogenate of rat small intestine. Int J Pharm 122 (1994) 133-141
72. Ishiura S., Nishikawa T., Tsukahara T., et al. Distribution of Alzheimer's disease amyloid A4-generating enzymes in rat brain tissue. Neurosci Lett 115 (1990) 329-334
73. Johnston J.A., Jensen M., Lannfelt L., Walker B., and Williams C.H. Inhibition of prolylendopeptidase does not affect gamma-secretase processing of amyloid precursor protein in a human neuroblastoma cell line. Neurosci Lett 277 (1999) 33-36
74. Petit A., Barelli H., Morain P., and Checler F. Novel proline endopeptidase inhibitors do not modify Abeta40/42 formation and degradation by human cells expressing wild-type and swedish mutated beta-amyloid precursor protein. Br J Pharmacol 130 (2000) 1613-1617
75. Shinoda M., Toide K., Ohsawa I., and Kohsaka S. Specific inhibitor for prolyl endopeptidase suppresses the generation of amyloid beta protein in NG108-15 cells. Biochem Biophys Res Commun 235 (1997) 641-645
76. Fukunari A., Kato A., Sakai Y., et al. Colocalization of prolyl endopeptidase and amyloid beta-peptide in brains of senescence-accelerated mouse. Neurosci Lett 176 (1994) 201-204
77. Kato A., Fukunari A., Sakai Y., and Nakajima T. Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse. J Pharmacol Exp Ther 283 (1997) 328-335
78. Leprince J, Cosquer D, Bellemère G, et al. Catabolism of the octadecaneuropeptide ODN by prolyl endopeptidase. Identification of an unusual cleavage site. Peptides, in press.
79. Chappell M.C., Tallant E.A., Brosnihan K.B., and Ferrario C.M. Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line. Peptides 11 (1990) 375-380
80. Greene L.J., Spadaro A.C., Martins A.R., Perussi De Jesus W.D., and Camargo A.C. Brain endo-oligopeptidase B: a post-proline cleaving enzyme that inactivates angiotensin I and II. Hypertension 4 (1982) 178-184
81. Shlank H., and Walter R. Enzymic cleavage of post-proline peptide bonds: degradation of arginine-vasopressin and angiotensin. Proc Soc Exp Biol Med 141 (1972) 452-455
82. Welches W.R., Santos R.A., Chappell M.C., Brosnihan K.B., Greene L.J., and Ferrario C.M. Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. J Hypertens 9 (1991) 631-638
83. Cavasin M.A., Rhaleb N.E., Yang X.P., and Carretero O.A. Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP. Hypertension 43 (2004) 1140-1145
84. Fruitier-Arnaudin I., Cohen M., Coitoux C., and Piot J.M. In vitro metabolism of LVV-Hemorphin-7 by renal cytosol and purified prolyl endopeptidase. Peptides 24 (2003) 1201-1206
85. Lew R.A., Tetaz T.J., Glucksman M.J., Roberts J.L., and Smith A.I. Evidence for a two-step mechanism of gonadotropin-releasing hormone metabolism by prolyl endopeptidase and metalloendopeptidase EC 3.4.24.15 in ovine hypothalamic extracts. J Biol Chem 269 (1994) 12626-12632
86. Lew R.A., Cowley M., Clarke I.J., and Smith A.I. Peptidases that degrade gonadotropin-releasing hormone: influence on LH secretion in the ewe. J Neuroendocrinol 9 (1997) 707-712
87. Yamanaka C., Lebrethon M.C., Vandersmissen E., et al. Early prepubertal ontogeny of pulsatile gonadotropin-releasing hormone (GnRH) secretion: I. Inhibitory autofeedback control through prolyl endopeptidase degradation of GnRH. Endocrinol 140 (1999) 4609-4615
88. Williams R.S., and Harwood A.J. Lithium therapy and signal transduction. Trends Pharmacol Sci 21 (2000) 61-64
89. Williams R.S. Pharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1029-1037
90. Cheng L., Lumb M., Polgar L., and Mudge A.W. How can the mood stabilizer VPA limit both mania and depression?. Mol Cell Neurosci 29 (2005) 155-161
91. Ohtsuki S., Homma K., Kurata S., Komano H., and Natori S. A prolyl endopeptidase of Sarcophaga peregrina (flesh fly): its purification and suggestion for its participation in the differentiation of the imaginal discs. J Biochem (Tokyo) 115 (1994) 449-453
92. Ishino T., Ohtsuki S., Homma K., and Natori S. cDNA cloning of mouse prolyl endopeptidase and its involvement in DNA synthesis by Swiss 3T3 cells. J Biochem (Tokyo) 123 (1998) 540-545
93. Ohtuski S., Homma K., Kurata S., and Natori S. Nuclear localization and involvement in DNA synthesis of Sarcophaga prolyl endopeptidase. J Biochem (Tokyo) 121 (1997) 1176-1181
94. Shan L., Molberg O., Parrot I., et al. Structural basis for gluten intolerance in celiac sprue. Science 297 (2002) 2275-2279
95. Diosdado B., van Oort E., and Wijmenga C. "Coelionomics": towards understanding the molecular pathology of coeliac disease. Clin Chem Lab Med 43 (2005) 685-695
96. Shan L., Qiao S.W., Arentz-Hansen H., et al. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J Proteome Res 4 (2005) 1732-1741
97. Diosdado B., Stepniak D.T., Monsuur A.J., et al. No genetic association of the human prolyl endopeptidase gene in the Dutch celiac diseasepopulation. Am J Physiol Gastrointest Liver Physiol 289 (2005) G495-G500
98. Hausch F., Shan L., Santiago N.A., Gray G.M., and Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol 283 (2002) G996-G1003
99. Piper J.L., Gray G.M., and Khosla C. Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo. J Pharmacol Exp Ther 311 (2004) 213-219
100. Marti T., Molberg O., Li Q., Gray G.M., Khosla C., and Sollid L.M. Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization. J Pharmacol Exp Ther 312 (2005) 19-26
101. Pyle G.G., Paaso B., Anderson B.E., et al. Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue. Clin Gastroenterol Hepatol 3 (2005) 687-694
102. Shan L., Marti T., Sollid L.M., Gray G.M., and Khosla C. Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue. Biochem J 383 (2004) 311-318
103. Gass J., Ehren J., Strohmeier G., Isaacs I., and Khosla C. Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: implications for Celiac Sprue therapy. Biotechnol Bioeng 92 (2005) 674-684
104. Matysiak-Budnik T., Candalh C., Cellier C., et al. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology 129 (2005) 786-796
105. Khosla C., Gray G.M., and Sollid L.M. Putative efficacy and dosage of prolyl endopeptidase for digesting and detoxifying gliadin peptides. Gastroenterology 129 (2005) 1362-1363
106. Siegel M., Bethune M.T., Gass J., et al. Rational design of combination enzyme therapy for celiac sprue. Chem Biol 13 (2006) 649-658
107. Gass J., Vora H., Bethune M.T., Gray G.M., and Khosla C. Effect of barley endoprotease EP-B2 on gluten digestion in the intact rat. J Pharmacol Exp Ther 318 (2006) 1178-1186
108. Santana J.M., Grellier P., Schrevel J., and Teixeira A.R. A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV. Biochem J 325 (1997) 129-137 [Pt 1]
109. Bastos I.M., Grellier P., Martins N.F., et al. Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells. Biochem J 388 (2005) 29-38
110. Joyeau R., Maoulida C., Guillet C., et al. Synthesis and activity of pyrrolidinyl- and thiazolidinyl-dipeptide derivatives as inhibitors of the Tc80 prolyl oligopeptidase from Trypanosoma cruzi. Eur J Med Chem 35 (2000) 257-266
111. Grellier P., Vendeville S., Joyeau R., et al. Trypanosoma cruzi prolyl oligopeptidase Tc80 is involved in nonphagocytic mammalian cell invasion by trypomastigotes. J Biol Chem 276 (2001) 47078-47086
112. O'Leary R.M., and O'Connor B. Identification and localisation of a synaptosomal membrane prolyl endopeptidase from bovine brain. Eur J Biochem 227 (1995) 277-283
113. Brandt I., De Vriendt K., Devreese B., et al. Search for substrates for prolyl oligopeptidase in porcine brain. Peptides 26 (2005) 2536-2546